Matches in SemOpenAlex for { <https://semopenalex.org/work/W2606222034> ?p ?o ?g. }
- W2606222034 endingPage "34" @default.
- W2606222034 startingPage "21" @default.
- W2606222034 abstract "Angiogenesis plays an essential role in rapid growing and metastasis of the tumors. Inhibition of angiogenesis is a putative strategy for cancer therapy. Endostatin (Es) is an attractive anti-angiogenesis protein with some clinical application challenges including; short half-life, instability in serum and requirement to high dosage. Therefore, production of recombinant endostatin (rEs) is necessary in large scale. The production of rEs is difficult because of its structural properties and is high-cost. Therefore, this review focused on the different expression systems that involved in rEs production including; mammalian, baculovirus, yeast, and Escherichia coli (E. coli) expression systems. The evaluating of the results of different expression systems declared that none of the mentioned systems can be considered to be generally superior to the other. Meanwhile with considering the advantages and disadvantage of E. coli expression system compared with other systems beside the molecular properties of Es, E. coli expression system can be a preferred expression system for expressing of the Es in large scale. Also, the molecular bioengineering and sustained release formulations that lead to improving of its stability and bioactivity will be discussed. Point mutation (P125A) of Es, addition of RGD moiety or an additional zinc biding site to N-terminal of Es , fusing of Es to anti-HER2 IgG or heavy-chain of IgG, and finally loading of the endostar by PLGA and PEG- PLGA nanoparticles and gold nano-shell particles are the effective bioengineering methods to overcome to clinical changes of endostatin." @default.
- W2606222034 created "2017-04-28" @default.
- W2606222034 creator A5002016601 @default.
- W2606222034 creator A5003546647 @default.
- W2606222034 creator A5025117323 @default.
- W2606222034 creator A5047125610 @default.
- W2606222034 creator A5082812386 @default.
- W2606222034 creator A5090703780 @default.
- W2606222034 date "2017-04-13" @default.
- W2606222034 modified "2023-09-28" @default.
- W2606222034 title "The Challenges of Recombinant Endostatin in Clinical Application: Focus on the Different Expression Systems and Molecular Bioengineering" @default.
- W2606222034 cites W1543678657 @default.
- W2606222034 cites W1550411102 @default.
- W2606222034 cites W1569373357 @default.
- W2606222034 cites W1579297325 @default.
- W2606222034 cites W165910174 @default.
- W2606222034 cites W1703240737 @default.
- W2606222034 cites W1963606936 @default.
- W2606222034 cites W1965696655 @default.
- W2606222034 cites W1968431199 @default.
- W2606222034 cites W1969638981 @default.
- W2606222034 cites W1970613781 @default.
- W2606222034 cites W1971491811 @default.
- W2606222034 cites W1972815780 @default.
- W2606222034 cites W1973684040 @default.
- W2606222034 cites W1979045879 @default.
- W2606222034 cites W1979212396 @default.
- W2606222034 cites W1979406058 @default.
- W2606222034 cites W1986677676 @default.
- W2606222034 cites W1987373390 @default.
- W2606222034 cites W1989772702 @default.
- W2606222034 cites W1991120755 @default.
- W2606222034 cites W1993992036 @default.
- W2606222034 cites W1994132667 @default.
- W2606222034 cites W1997107937 @default.
- W2606222034 cites W1998909889 @default.
- W2606222034 cites W2000808983 @default.
- W2606222034 cites W2001599379 @default.
- W2606222034 cites W2004693148 @default.
- W2606222034 cites W2005384351 @default.
- W2606222034 cites W2006108263 @default.
- W2606222034 cites W2008321434 @default.
- W2606222034 cites W2009898602 @default.
- W2606222034 cites W2009970806 @default.
- W2606222034 cites W2019703059 @default.
- W2606222034 cites W2026022612 @default.
- W2606222034 cites W2027414605 @default.
- W2606222034 cites W2027790437 @default.
- W2606222034 cites W2028332715 @default.
- W2606222034 cites W2030821918 @default.
- W2606222034 cites W2032738969 @default.
- W2606222034 cites W2033288159 @default.
- W2606222034 cites W2034766668 @default.
- W2606222034 cites W2034969165 @default.
- W2606222034 cites W2035396624 @default.
- W2606222034 cites W2039259051 @default.
- W2606222034 cites W2041116703 @default.
- W2606222034 cites W2042091128 @default.
- W2606222034 cites W2046484907 @default.
- W2606222034 cites W2048293656 @default.
- W2606222034 cites W2049322319 @default.
- W2606222034 cites W2050818228 @default.
- W2606222034 cites W2051359139 @default.
- W2606222034 cites W2054484461 @default.
- W2606222034 cites W2056349974 @default.
- W2606222034 cites W2057214857 @default.
- W2606222034 cites W2059798536 @default.
- W2606222034 cites W2059983738 @default.
- W2606222034 cites W2063787270 @default.
- W2606222034 cites W2069882466 @default.
- W2606222034 cites W2074487444 @default.
- W2606222034 cites W2075780259 @default.
- W2606222034 cites W2076372152 @default.
- W2606222034 cites W2078768896 @default.
- W2606222034 cites W2078868629 @default.
- W2606222034 cites W2084099994 @default.
- W2606222034 cites W2091866599 @default.
- W2606222034 cites W2098798735 @default.
- W2606222034 cites W2104485396 @default.
- W2606222034 cites W2105199681 @default.
- W2606222034 cites W2109069210 @default.
- W2606222034 cites W2111833798 @default.
- W2606222034 cites W2122096535 @default.
- W2606222034 cites W2122251126 @default.
- W2606222034 cites W2124145112 @default.
- W2606222034 cites W2125112404 @default.
- W2606222034 cites W2127119764 @default.
- W2606222034 cites W2131798870 @default.
- W2606222034 cites W2134566626 @default.
- W2606222034 cites W2135832539 @default.
- W2606222034 cites W2139671257 @default.
- W2606222034 cites W2140724459 @default.
- W2606222034 cites W2146590089 @default.
- W2606222034 cites W2157515404 @default.
- W2606222034 cites W2157647295 @default.
- W2606222034 cites W2157815481 @default.
- W2606222034 cites W2173693631 @default.
- W2606222034 cites W2188996997 @default.